A Single Ascending Dose of HRS-2162 in Healthy Subjects

Clinical trial NCT07195604 · RECRUITING

Trial details

NCT number: NCT07195604
Sponsor: Fujian Shengdi Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Reversal of Neuromuscular Blockade

Start date: 2025-09-25
Primary completion: 2025-12-01
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.